Have a personal or library account? Click to login
Defect in Mitochondrial NADH-Dehydrogenase Genes in Canine Mast Cell Tumours Cover

Defect in Mitochondrial NADH-Dehydrogenase Genes in Canine Mast Cell Tumours

Open Access
|Aug 2020

References

  1. Blackwood L., Murphy S., Buracco P., De Vos J.P., De Fornel-Thibaud P., Hirschberger J., Kessler M., Pastor J., Savary-Bataille K., Argyle D.J. (2012). European consensus document on mast cell tumours in dogs and cats. Vet. Comp. Oncol., 10: e1-e29.10.1111/j.1476-5829.2012.00341.x
  2. Combet C., Blanchet C., Geourjon C., Deleage, G. (2000). NPS@: network protein sequence analysis. Trends Biochem. Sci., 25: 147–150.10.1016/S0968-0004(99)01540-6
  3. HGVS recommendations for the description of sequence variants: 2016 update. Den Dunnen et al. 2016. Hum. Mutat., 37: 564–569.10.1002/humu.2298126931183
  4. DNA Baser Sequence Assembler 3.2. Heracle BioSoft SRL Romania. (2012). http://www.DnaBaser.com.
  5. Gasteiger E., Hoogland C., Gattiker A., Wilkins M.R., Appel R.D., Bairoch A. (2005). Protein identification and analysis tools on the ExPASy server. In: The proteomics protocols handbook (pp. 571–607). Humana press.10.1385/1-59259-890-0:571
  6. Grzybowska-Szatkowska L., Ślaska B. (2014). Mitochondrial NADH dehydrogenase polymorphisms are associated with breast cancer in Poland. J. App. Genet., 55: 173–181.10.1007/s13353-013-0190-9
  7. Grzybowska-Szatkowska L., Ślaska B., Rzymowska J., Brzozowska A., Floriańczyk B. (2014). Novel mitochondrial mutations in the ATP6 and ATP8 genes in patients with breast cancer. Mol. Med. Rep., 10: 1772–1778.10.3892/mmr.2014.2471
  8. Hendrick M.J., Mahaffey E.A., Moore J.H., Walder E.J. (1998). Histological Classification of Mesenchymal Tumors of Skin and Soft Tissues of Domestic Animals. In: WHO International Histological Classification of Tumors of Domestic Animals. Second Series. Washington: Armed Forces Institute of Pathology 2: 28–29.
  9. Kim S.K., Lee S.E., Jeong H. Ha J.H. (1998). The Complete Nucleotide Sequence of the Domestic Dog (Canis familiaris) Mitochondrial Genome. Mol. Phylogenet. Evol., 10: 210–220.10.1006/mpev.1998.0513
  10. Kimchi-Sarfaty C., Oh J.M., Kim I.W., Sauna Z.E., Calcagno A.M., Ambudkar S.V., Gottesman M.M. (2007). A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science, 315: 525–528.10.1126/science.1135308
  11. Kiupel M., Webster J.D., Bailey K.L., Best S., DeLay J., Detrisac C.J., Fitzgerald, S.D., Gamble, D., Ginn, P.E., Goldschmidt, M.H., Hendrick, M.J. (2011). Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Vet. Pathol., 48: 147–155.10.1177/0300985810386469
  12. Kumar S., Stecher G., Tamura K. (2016) MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets. Mol. Biol. Evol., 33: 1870–1874.10.1093/molbev/msw054
  13. Leidinger E.F., Freeman K., Kirtz G., Hooijberg E.H., Sick K. (2014). Breed related odds ratio and anatomic distribution of canine mast cell tumours in Austria. Retrospective study of cases in the years 2000–2010. Tierarztl Prax. K. H., 42: 367–373.10.15654/TPK-140165
  14. Letard S., Yang Y., Hanssens K., Palmérini F., Leventhal P.S., Guéry S., Moussy A., Kinet J.P., Hermine O., Dubreuil P. (2008). Gain-offunction mutations in the extracellular domain of KIT are common in canine mast cell tumors. Mol. Cancer Res., 6: 1137–1145.10.1158/1541-7786.MCR-08-0067
  15. Lu J., Sharma L.K., Bai Y. (2009). Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res., 19: 802–815.10.1038/cr.2009.69
  16. Nackley A.G., Shabalina S.A., Tchivileva I.E., Satterfield K., Korchynskyi O., Makarov S.S., Maixner W., Diatchenko L. (2006). Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science, 314: 1930–1933.10.1126/science.1131262
  17. Neelamathi E., Vasumathi E., Bagyalakshmi S., Kannan R. (2009). Insilico prediction of structure and functional aspects of a hypothetical protein of Neurospora crassa. Cell Tissue Res., 9: 1889–1894.
  18. Parmley J.L., Hurst L.D. (2007). How do synonymous mutations affect fitness? Bioessays, 29: 515–519.10.1002/bies.2059217508390
  19. Pionnier-Capitan M., Bemilli C., Bodu P., Celerier G., Ferrie J.G., Fosse P., Garcia M., Vigne J.D. (2011). New evidence for Upper Palaeolithic small domestic dogs in South-Western Europe. J. Archaeol. Sci., 38: 2123–2140.10.1016/j.jas.2011.02.028
  20. Slaska B., Grzybowska-Szatkowska L., Nisztuk S., Surdyka M., Rozanska D. (2015). Mitochondrial DNA polymorphism in genes encoding ND1, COI and CYTB in canine malignant cancers. Mitochondr. DNA., 26: 452–458.10.3109/19401736.2013.840594
  21. Slaska B., Grzybowska-Szatkowska L., Surdyka M., Nisztuk S., Różańska D., Różański P., Śmiech A., Orzelski M. (2014). Mitochondrial D-loop mutations and polymorphisms are connected with canine malignant cancers, Mitochondr. DNA, 25: 238–243.10.3109/19401736.2013.792054
  22. Ślaska B., Grzybowska-Szatkowska L., Bugno-Poniewierska M., Gurgul A., Śmiech A., Różańska D., Dudka J. (2016). Relevance of molecular changes in the ND4 gene in German Shepherd dog tumors. Pol. J. Vet. Sci., 19: 461–469.10.1515/pjvs-2016-0058
  23. Ślaska B., Grzybowska-Szatkowska L., Bugno-Poniewierska M., Surdyka M., Śmiech A. (2013). Nuclear and mitochondrial DNA mutation in human and canine tumors. Med. Weter., 69: 195–202.
  24. Ślaska B., Surdyka M., Brodzki A., Nisztuk S., Gurgul A., Bugno-Poniewierska M., Śmiech A., Różańska D., Orzelski M. (2014). Mitochondrial D- loop mutations can be detected in sporadic malignant tumors in dogs. B. Vet. I. Pulawy, 631-637.10.2478/bvip-2014-0096
  25. Śmiech A., Ślaska B., Bownik A., Grzybowska-Szatkowska, L., Dudka J., Łopuszyński W. (2019). Heteroplasmic Mutations and Polymorphisms in the Cyb Gene of Mitochondrial DNA in Canine Mast Cell Tumors. In Vivo, 33: 57–63.10.21873/invivo.11439
  26. Śmiech A., Ślaska B., Łopuszyński W., Jasik A., Bochyńska D., Dąbrowski R. (2018). Epidemiological assessment of the risk of canine mast cell tumours based on the Kiupel two-grade malignancy classification. Acta Vet. Scand., 60:70.10.1186/s13028-018-0424-2
  27. Śmiech A., Ślaska B., Łopuszyński W., Jasik A., Szczepanik M., Wilkołek P. (2017). Epidemiological study of canine mast cell tumours according to the histological malignancy grade. Pol. J. Vet. Sci., 20: 455–465.10.1515/pjvs-2017-0055
  28. Śmiech A., Ślaska B., Surdyka M., Grzybowska-Szatkowska L., Łopuszyński W., Różańska D. (2016). Identification of additional mitochondrial DNA mutations in canine mast cell tumours. Acta Vet. Scand., 58:28.10.1186/s13028-016-0210-y
  29. Sledge D.G., Webster, J., Kiupel M. (2016). Canine cutaneous mast cell tumors: A combined clinical and pathologic approach to diagnosis, prognosis, and treatment selection. Vet. J., 215: 43–54.10.1016/j.tvjl.2016.06.003
  30. Surdyka M., Slaska B. (2017a). Defect of the mitochondrial DNA hypervariable region as a risk factor for canine mammary tumor. Vet. Comp. Oncol., 15: 820–828.10.1111/vco.1222427198058
  31. Surdyka M., Slaska B. (2017b). Defect in ND2, COX2, ATP6, and COX3 mitochondrial genes as a risk factor for canine mammary tumor. Vet. Comp. Oncol., 15: 1062–1072.10.1111/vco.1224727278673
  32. Tang H., Thomas P.D. (2016). PANTHER-PSEP: predicting disease-causing genetic variants using position-specific evolutionary preservation. Bioinformatics, 32: 2230–2232.10.1093/bioinformatics/btw222
  33. Vascellari M., Giantin M., Capello K., Carminato A., Morello E. M., Vercelli A., Granato A., Buracco P., Dacasto M., Mutinelli, F. (2013). Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis. Vet. Pathol., 50: 110–121.10.1177/0300985812447829
  34. Wallace D.C. (2012). Mitochondria and cancer. Nat. Rev. Cancer., 12: 685–698.10.1038/nrc3365
  35. Webster, J. D., Yuzbasiyan-Gurkan, V., Kaneene, J. B., Miller, R., Resau, J. H., Kiupel, M. (2006). The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors. Neoplasia (New York, NY), 8: 104–111.10.1593/neo.05622
  36. Webster J.D., Yuzbasiyan-Gurkan V., Miller R.A., Kaneene J.B., Kiupel M. (2007). Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication. Vet. Pathol., 44: 298–308.10.1354/vp.44-3-298
  37. Welle M.M., Bley C.R., Howard J., Rüfenacht S. (2008). Canine Mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment. Vet. dermatol., 19: 321–339.10.1111/j.1365-3164.2008.00694.x
DOI: https://doi.org/10.2478/aoas-2020-0027 | Journal eISSN: 2300-8733 | Journal ISSN: 1642-3402
Language: English
Page range: 919 - 937
Submitted on: Oct 17, 2019
Accepted on: Feb 27, 2020
Published on: Aug 1, 2020
Published by: National Research Institute of Animal Production
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2020 Brygida Ślaska, Anna Śmiech, Adam Bownik, Krzysztof Kowal, Angelika Tkaczyk, Mariusz Pierzchała, Jarosław Dudka, published by National Research Institute of Animal Production
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.